Manuscripts
Showing 1592 manuscripts.
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.
Citation
Jennifer R. King, Pharm.D., Edward P. Acosta, Pharm.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., Bobbie L. Graham, B.S., Vincent J. Carey, Ph.D., Paula Britto, M.S. Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients. Pediatric Infectious Disease Journal. 2009 Feb 01; 28(2):159-161. PMID: 19106779; PMCID: PMC2755569.Year
2009
Journal
Pediatric Infectious Disease Journal
Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.
Citation
Patricia A. Garvie, Ph.D., Joanne Lawford, Ph.D., Patricia M. Flynn, M.D., M.S., Aditya Gaur, M.D., Marvin Eric Belzer, M.D., George D. McSherry, M.D., Lawrence B. Friedman, M.D., ChengCheng Hu, Ph.D. Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability. Journal of Adolescent Health. 2009 Feb 01; 44(2):124-32. PMID: 19167660; PMCID: PMC2659610.Year
2009
Journal
Journal of Adolescent Health
Study
P1036A
Allocation of family responsibility for illness management in pediatric HIV.
Citation
Sylvie Naar-King, M.D., Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., John J. Farley, M.D., M.P.H., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Kathleen Malee, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D. Allocation of family responsibility for illness management in pediatric HIV. Journal of Pediatrics. 2009 Mar 01; 34(2):187-94. PMID: 18586756; PMCID: PMC2722122.Year
2009
Journal
Journal of Pediatrics
Study
P1042S
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.
Citation
Anne Butler, M.S., Paige L. Williams, Ph.D., Lois C. Howland, M.S., M.P.H., D.Ph., Deborah S. Storm, R.N.,Ph.D, Nancy Hutton, M.D., George Seage, III, Sc.D., M.P.H. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics. 2009 Mar 11; 123(3):935-43. PMID: 19255023; PMCID: PMC2697844.Year
2009
Journal
Pediatrics
Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team
Citation
Grace M. Aldrovandi, MD, Jane C. Lindsey, Sc.D., Denise L. Jacobson, Amanda Zadzilka, B.S., Elizabeth Sheeran, M.S., R.D., John ( Jack ) Moye, Jr., M.D., Peggy R. Borum, Ph.D., William A. Meyer, III, Ph.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D. Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team. AIDS. 2009 Mar 27; 23(6):661-72. PMID: 19279441; PMCID: PMC2680185.Year
2009
Journal
AIDS
Study
P1045
Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort
Citation
Thomas Valente, Ph.D., Jennifer B. Zogg, Ph.D., Jean Richardson, Ph.D., Andrea Kovacs, M.D., Eva A. Operskalski, Ph.D., M.B.A. Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort. Journal of Acquired Immune Deficiency Syndromes. 2009 Dec 01; 52(4):514-23. PMID: 19584741; PMCID: PMC2783777.Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.
Citation
John W. Sleasman, M.D., Brian Robbins, Ph.D., Shane Cross, Pharm.D., Jane C. Lindsey, Sc.D., Barbara E. Heckman, B.S., H.G. Sprenger, M.D., Nancy Tustin, M.L.T., (ASCP), Charles Rose, Gary E. Pakes, Pharm.D., Edmund Capparelli, Pharm.D., P Poston, E Neal, M Nikanjam. Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults. Clinical Pharmacology & Therapeutics. 2009 Apr 01; 85(4):394-401. PMID: 19118380; PMCID: PMC2767189.Year
2009
Journal
Clinical Pharmacology & Therapeutics
Study
P1052
Human immunodeficiency virus type-1 infection inhibits autophagy.
Citation
Dejiang Zhou, Stephen A. Spector, M.D. Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS. 2009 Mar 30; 22(6):695-9. PMID: 18356598; PMCID: PMC2764485.Year
2009
Journal
AIDS
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
Citation
David W Ouyang, David E Shapiro, Ming Lu, Susan B Brogly, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala, Ronald C Hershow. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS. 2009 Nov 27; 23(18):2425-30. PMID: 19617813; PMCID: PMC2783653.Year
2009
Journal
AIDS
Study
P1025
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution
Citation
Paige L. Williams, Ph.D., Julia (Wei) Wu, M.S., Susan Ellen Cohn, M.D., M.P.H., Susan L. Koletar, M.D., J. Allen McCutchan, M.D., M.Sc., Robert L. Murphy, M.D., Judith Silverstein Currier, M.D., M.Sc. Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Medicine. 2009 May 01; 10(5):290-301. PMCID: PMC2778216.Year
2009
Journal
HIV Medicine